Mitchell Lab’s Targeted Prenatal Therapy for Mothers and Their Babies Addresses Gap in Health Equity
The researchers’ successful trials in mice show that the technology may potentially lead to promising treatment options for humans with pre-eclampsia.
Penn Medicine, CHOP receive $25M anonymous gift to accelerate research in rare genetic brain disorders
The donation will establish the Center for Epilepsy and Neurodevelopmental Disorders, which will initially focus on developing therapies for disorders related to genetic mutations that are linked to a
Eidos LGBTQ+ Health Initiative Support Advances in LGBTQIA+ Health Startups
The goal of the partnership is to support founders and entrepreneurs with in-depth LGBTQ+ health knowledge and research expertise.
Equimeter Wins $10,000 2023 Penn Y-Prize
The Equimeter team consisted of undergraduates Ujjayi Pamidigantam (Vagelos LSM), Parthiv Patel (Vagelos LSM), and Advait T. (Vagelos LSM)
Nia Therapeutics and Peroxitech Raise Venture Funding
Two Penn spinout companies have recently brought in major investments to help further advance their technologies.
Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery
In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.
Three Penn Spinouts Made Philadelphia Business Journal’s PHLInno List of Top Philadelphia Startups to Watch in 2023
Exciting news for three innovative Penn spinouts.
Katalin Karikó and Drew Weissman named to the National Inventors Hall of Fame
Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.
Exyn Technologies Secures $35M in Series B Funding
Penn spinout Exyn Technologies, a pioneer in multi-platform robotic autonomy for complex, GPS-denied environments, had a $35 million Series B round at the end of 2022.
Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting
Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.